Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: a real-world observation study

Abstract Purpose This study was performed to investigate the efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer (NSCLC) in the real world. Methods Data on clinicopathological features, efficacy and adverse events (AEs) were collected retr...

Full description

Bibliographic Details
Main Authors: Ke Ma, Qianqian Guo, Xingya Li
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12890-023-02470-z